Reports Q3 revenue $330.99M, consensus $346.28M. “We delivered another strong quarter on all metrics. This demonstrates the strength of our model during a period where other approaches are facing significant headwinds,” said Clover Health (CLOV) CEO Andrew Toy. “Underpinned by our ability to use technology to empower any physician on a wide network, our results position us to drive membership growth while maintaining strong underlying financial performance. I am proud that, powered by Clover Assistant, our health plans are anchored on identifying and managing diseases as early as possible to better control the total cost of care. This has also contributed to our market-leading HEDIS performance and achievement of 4.0 Stars for our flagship PPO plan for payment year 2026. We believe this validates our care platform and positions us well to invest in growth in both our core Insurance plans and Counterpart offering.”
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLOV:
- Clover Health options imply 13.9% move in share price post-earnings
- Clover Health announces debut of its 2025 MA plan offerings in New Jersey
- Clover Health Earns 4-Star CMS Rating, Anticipates Growth
- Clover Health’s Counterpart Health names David Tsay Chief Medical Officer
- Clover Health initiated with a Neutral at UBS